Dublin, Ireland – At ISCT 2026 in Dublin, Safia Guleed represented Strike Pharma among researchers, clinicians, and industry professionals within the cell and gene therapy community.

The meeting provided valuable opportunities to exchange scientific perspectives, discuss emerging innovations, and explore future opportunities in translational medicine. The event also highlighted the rapid development of the field and the continued importance of collaboration across academia, healthcare, and industry to advance next-generation therapies.